Viral Hepatitis Research Program (VHRP)

BC-CfE researchers attend world’s most influential meeting on HIV research

The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings. Taking place virtually from Berlin, IAS 2021 saw around 6,000 participants and opened with remarks from German Chancellor Angela Merkel and included

BC-CfE researchers attend world’s most influential meeting on HIV research Read More »

Hepatitis C could be wiped out in NI in five years under new plan, says Robin Swann

Health Minister Robin Swann has said hepatitis C could be wiped out in Northern Ireland within five years. The minister was speaking after his department, alongside the Public Health Agency, published a new action plan to eliminate the disease here by 2025 – five years ahead of the target set by the World Health Organisation.

Hepatitis C could be wiped out in NI in five years under new plan, says Robin Swann Read More »

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar

The BC-CfE’s Nance Cunningham, an Experimental Medicine PhD student working in the EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS) has been chosen as a UBC Public Scholar.The Public Scholars Initiative (PSI)supports creative, action-oriented research designed to address complex challenges and have meaningful public impact as part of a PhD thesis. The award will support Cunningham’s research partnerships with people affected by hepatitis C, and patient advocacy activists.

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar Read More »

BC-CfE contributes to vital dialogue at a virtual 23rd International AIDS Conference

The fitting theme of AIDS 2020, the first fully-virtual International AIDS Conference, was Resilience. The theme reminded the global HIV community of its ability to come together despite a global pandemic to share our commitment to HIV prevention, treatment and cure research. More than 180 countries participated in this year’s conference, held during the second

BC-CfE contributes to vital dialogue at a virtual 23rd International AIDS Conference Read More »

Power combo: Harm reduction plus effective treatment help prevent spread of Hepatitis C

Fifty-three year old Vancouver resident Sage Rinaldo lived with hepatitis C for many years before working up the courage to seek treatment. Rinaldo credits a community health nurse in the Downtown Eastside who gained her trust and helped her successfully treat her hepatitis C with a new anti-viral treatment. Now, Rinaldo is giving back by

Power combo: Harm reduction plus effective treatment help prevent spread of Hepatitis C Read More »

The BC-CfE’s Per-SVR Team Fights for HCV Awareness

Globally, 290 million people are unaware they are living with a hepatitis C virus (HCV) infection. This significant global health problem affects as many as 80,000 individuals here in BC. Today on World Hepatitis Day, the theme is ‘Find the Missing Millions’ in order to raise awareness of the global burden of viral hepatitis and to influence real change.

The BC-CfE’s Per-SVR Team Fights for HCV Awareness Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)